MediPharm Labs Corp (MEDIF)
0.0628
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
MediPharm Labs Debt to Equity Ratio: 0.0397 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0397 |
| September 30, 2023 | 0.0446 |
| June 30, 2023 | 0.0461 |
| March 31, 2023 | 0.0024 |
| December 31, 2022 | 0.0093 |
| September 30, 2022 | 0.0172 |
| June 30, 2022 | 0.0188 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0192 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0158 |
| March 31, 2021 | 0.0261 |
| December 31, 2020 | 0.2285 |
| September 30, 2020 | 0.2908 |
| June 30, 2020 | 0.131 |
| March 31, 2020 | 0.0788 |
| December 31, 2019 | 0.0728 |
| September 30, 2019 | 0.0465 |
| June 30, 2019 | 0.0496 |
| March 31, 2019 | 0.1751 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
0.2908
Maximum
Sep 2020
0.0599
Average
0.0397
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 48.20M |
| Total Liabilities (Quarterly) | 8.241M |
| Shareholders Equity (Quarterly) | 39.96M |
| Current Ratio | 3.372 |
| Net Debt Paydown Yield | -0.85% |